Myth #1: PBMs are middlemen that incentivize drug manufacturers to raise drug list prices so they can negotiate higher rebates and increase their own profits
Fact: Only drug manufacturers have the power to set and raise drug prices. PBMs are the only counterweight working to lower medication costs by negotiating on behalf of plan sponsors to keep costs as low as possible for clients and consumers.
In fact, in January 2025, Optum Rx announced that 100% of rebates will be passed through to clients by 2028. Prior to January 2025, 98% of rebates were passed through to clients.